Literature DB >> 18855620

Regulation of thrombospondin1 by extracellular proteases.

M Luisa Iruela-Arispe1.   

Abstract

The contribution of proteases to developmental, physiological and pathological processes has been well accepted. Cleavage of matrix proteins is a key requirement for cell migration and remodeling of the extracellular environment. The constant process of matrix turnover is dependent on the delicate balance between degradation and synthesis. In addition, regulated proteolysis also allows for the release and activation of growth factors and cytokines. Similarly to other extracellular matrix proteins, thrombospondins are also targets of proteolysis. While in some cases enzymatic activity is associated with degradation of the protein; in other situations, targeted and selective cleavage offers the means to release polypeptides with either alternative or enhanced function. Here, we provide a summary of the published information related to thrombospondin proteolysis within the context of how proteolysis of extracellular matrix proteins impacts diversification of protein function. We also discuss its biological relevance and potential therapeutic value of thrombospondin proteolysis with particular emphasis on angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855620      PMCID: PMC3010394          DOI: 10.2174/138945008785909365

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  69 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.

Authors:  N Guo; H C Krutzsch; J K Inman; D D Roberts
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

Review 3.  The thrombospondin type 1 repeat superfamily.

Authors:  Richard P Tucker
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

Review 4.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 5.  The cell biology of thrombospondin-1.

Authors:  H Chen; M E Herndon; J Lawler
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

6.  Thrombin and chymotrypsin interactions with thrombospondin.

Authors:  J Lawler; J E Connolly; P Ferro; L H Derick
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

7.  Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis.

Authors:  K Gupta; P Gupta; R Wild; S Ramakrishnan; R P Hebbel
Journal:  Angiogenesis       Date:  1999       Impact factor: 9.596

8.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

9.  Proteolysis of thrombospondin during cathepsin-G-induced platelet aggregation: functional role of the 165-kDa carboxy-terminal fragment.

Authors:  S Rabhi-Sabile; D Pidard; J Lawler; P Renesto; M Chignard; C Legrand
Journal:  FEBS Lett       Date:  1996-05-13       Impact factor: 4.124

10.  Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1.

Authors:  S Godyna; G Liau; I Popa; S Stefansson; W S Argraves
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  12 in total

1.  The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.

Authors:  Mariya T Sweetwyne; Manuel A Pallero; Ailing Lu; Lauren Van Duyn Graham; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 2.  Thrombospondins in the transition from myocardial infarction to heart failure.

Authors:  Jonathan A Kirk; Oscar H Cingolani
Journal:  J Mol Cell Cardiol       Date:  2015-12-10       Impact factor: 5.000

Review 3.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 4.  Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.

Authors:  Patrick R Lawler; Jack Lawler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

5.  Investigation of thrombospondin-1 and transforming growth factor-β expression in the heart of aging mice.

Authors:  Huabo Cai; Zhanggen Yuan; Qing Fei; Jiayao Zhao
Journal:  Exp Ther Med       Date:  2011-12-20       Impact factor: 2.447

6.  Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.

Authors:  Yoon-Jin Lee; Moritz Koch; Daniel Karl; Antoni X Torres-Collado; Namali T Fernando; Courtney Rothrock; Darshini Kuruppu; Sandra Ryeom; M Luisa Iruela-Arispe; Sam S Yoon
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

7.  Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine.

Authors:  Raffaele Altara; Marco Manca; Ramzi Sabra; Assaad A Eid; George W Booz; Fouad A Zouein
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

8.  Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissue.

Authors:  Jennifer A Rohrs; Christopher D Sulistio; Stacey D Finley
Journal:  NPJ Syst Biol Appl       Date:  2016-10-20

9.  A mechanistic evaluation of the angiogenic properties of a dehydrated amnion chorion membrane in vitro and in vivo.

Authors:  John P McQuilling; Miranda Burnette; Kelly A Kimmerling; MaryRose Kammer; Katie C Mowry
Journal:  Wound Repair Regen       Date:  2019-08-29       Impact factor: 3.617

10.  TP53 Status is Associated with Thrombospondin1 Expression In vitro.

Authors:  Angeles Alvarez Secord; Marcus Q Bernardini; Gloria Broadwater; Lisa A Grace; Zhiqing Huang; Tsukasa Baba; Eiji Kondoh; Gregory Sfakianos; Laura J Havrilesky; Susan K Murphy
Journal:  Front Oncol       Date:  2013-10-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.